GFAP and neurodegenerative disease: IU1 treatment in mouse embryonic fibroblasts (MEFs) and HEK293 cells promoted degradation of several proteasome substrates associated with neurodegenerative diseases, such as tau, TDP‐43, ATXN3, and glial fibrillary acidic protein (GFAP) [164].